“…Covid-19 patients present increased levels of IL-1, IL-2, IL-4, IL-7, IL-10, IL-12, IL-13, IL-17, GCSF, MCSF, IP-10, MCP-1, MIP-1α, HGF, IFN-γ, and TNF-α (Guo et al, 2020 ). Vagal afferents in the lungs detect inflammatory tissue-damaging stimuli (Carr and Undem, 2003 ), while VNS reduces the storm of pro-inflammatory cytokines through ChAP and HPAA activation, without leading to immunosuppression (Dos Santos et al, 2011 ; Krzyzaniak et al, 2011 ; Akella and Deshpande, 2015 ; Huang et al, 2019 ). Consequently, we expect VNS to reduce the severity of Covid-19 inflammation-related complications and fatalities while preventing strong and deteriorating immune responses.…”